Home Newsfeeds Cleveland Research Downgrades Target to Neutral

Cleveland Research Downgrades Target to Neutral

Cleveland Research downgrades Target (NYSE:TGT) from Buy to Neutral.

byBenzinga Newsdesk

December 12, 2022

1 minute read

Cleveland Research downgrades Target (NYSE:TGT) from Buy to Neutral.

B of A Securities Initiates Coverage On Cadre Hldgs with Buy Rating, Announces Price Target of $30

By Benzinga Newsdesk

September 6, 6:27 AM

B of A Securities analyst Ronald Epstein initiates coverage on Cadre Hldgs (NYSE:CDRE) with a Buy rating and announces Price Target of $30.

CDRE

Netflix Gets Price Target Bumps By Analysts After Q4 Results

By Lisa Levin

January 20, 12:23 PM

Netflix Inc (NASDAQ: NFLX) reported downbeat earnings for the fourth quarter, while sales topped expectations.

NFLX

News

“U2’s First Batch Of Shows At The Sphere Generated Nearly $110M In Ticket Sales” – Billboard

By Benzinga Newsdesk

November 28, 4:18 PM

https://www.billboard.com/pro/u2-shows-sphere-110-million-ticket-sales/ U2 wrapped the first leg of the U2:UV Achtung Baby Live at Sphere residency on Nov. 4 with unprecedented box-office results. According to

SPHR

Top 4 Consumer Stocks That May Collapse This Month

By Avi Kapoor

January 16, 8:47 AM

As of Jan. 16, 2024, four stocks in the consumer discretionary sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.

BNED

Cleveland Research Downgrades Target to Neutral

Related Posts

B of A Securities Initiates Coverage On Cadre Hldgs with Buy Rating, Announces Price Target of $30

Netflix Gets Price Target Bumps By Analysts After Q4 Results

“U2’s First Batch Of Shows At The Sphere Generated Nearly $110M In Ticket Sales” – Billboard

Top 4 Consumer Stocks That May Collapse This Month